{"id":2049,"date":"2019-01-08T13:38:32","date_gmt":"2019-01-08T12:38:32","guid":{"rendered":"https:\/\/www.maiwald.eu\/all\/presseberichte\/germany-district-court-lifts-several-ex-parte-preliminary-injunctions-granted-for-merck-sharpe-dohme-corp-the-spc-blog\/"},"modified":"2021-10-01T16:29:05","modified_gmt":"2021-10-01T14:29:05","slug":"germany-district-court-lifts-several-ex-parte-preliminary-injunctions-granted-for-merck-sharpe-d","status":"publish","type":"presseberichte","link":"https:\/\/www.maiwald.eu\/jp\/press-coverage\/germany-district-court-lifts-several-ex-parte-preliminary-injunctions-granted-for-merck-sharpe-d\/","title":{"rendered":"Germany &#8211; District Court lifts several ex-parte preliminary injunctions granted for Merck Sharpe &#038; Dohme Corp. (The SPC Blog)"},"content":{"rendered":"\n<p>Recently, the District Court in D\u00fcsseldorf lifted several ex-parte preliminary injunctions granted for Merck Sharpe &amp; Dohme Corp. (MSD) against various generic companies. Subject of the proceedings is the cholesterol-lowering combination product Inegy\u00ae. Inegy\u00ae is a fixed dose combination of the actives ingredients ezetimibe and simvastatin. <a href=\"https:\/\/www.maiwald.eu\/jp\/team\/derk-vos\/\" target=\"_top\" rel=\"noopener\">Dr Derk Vos<\/a> (Maiwald) represented Hexal in the proceedings.<\/p>\n\n\n\n<p>The complete The SPC Blog article can be downloaded here:<\/p>\n\n\n\n<p><a href=\"http:\/\/thespcblog.blogspot.com\/2018\/11\/germany-district-court-lifts-several-ex.html\" target=\"_blank\" rel=\"noopener\">http:\/\/thespcblog.blogspot.com\/2018\/11\/germany-district-court-lifts-several-ex.html<\/a><\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2049","presseberichte","type-presseberichte","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/presseberichte\/2049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/presseberichte"}],"about":[{"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/types\/presseberichte"}],"version-history":[{"count":1,"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/presseberichte\/2049\/revisions"}],"predecessor-version":[{"id":9268,"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/presseberichte\/2049\/revisions\/9268"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/media?parent=2049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}